Localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue: Influence of liposome characteristics

Biochimica et Biophysica Acta - Biomembranes

Volumn 1421, Issue 2, 1999, Pages 329-339

  Schiffelers, Raymond M ^a,b   Bakker Woudenberg, Irma A J M ^b   Snijders, Susan V ^b   Storm, Gert ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Infection; Pharmacokinetics; Pneumonia; Poly(ethylene glycol); Rat; Sterically stabilized liposome; Targeting

Indexed keywords

DRUG CARRIER; GENTAMICIN; LIPOSOME; MACROGOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCULATION TIME; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG TARGETING; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; KLEBSIELLA PNEUMONIAE; LUNG INFECTION; LUNG PARENCHYMA; MEMBRANE FLUIDITY; NONHUMAN; PARTICLE SIZE; PNEUMONIA; PRIORITY JOURNAL; RAT; STEREOSPECIFICITY;

ANIMALS; ANTI-BACTERIAL AGENTS; FEMALE; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LIPOSOMES; LUNG; MEMBRANE FLUIDITY; PARTICLE SIZE; PHOSPHOLIPIDS; PNEUMONIA; POLYETHYLENE GLYCOLS; RATS; SPECIFIC GRAVITY; SPECIFIC PATHOGEN-FREE ORGANISMS; TISSUE DISTRIBUTION;

KLEBSIELLA PNEUMONIAE;

EID: 0032871007     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2736(99)00139-X     Document Type: Article

References (36)

1. M. Venditti, P. Martino, The importance of in-vitro susceptibility testing in the management of compromised hosts, J. Chemother. 9S1 (1997) 116-122.
2. J.D. Butts, Intracellular concentrations of antibacterial agents and related clinical implications, Clin. Pharmacokinet. 27 (1994) 63-84.
3. R.H. Rubin, Fungal and bacterial infections in the immuno-compromised host, Eur. J. Clin. Microbiol. Inf. Dis. 12S1 (1993) S42-48.
4. K.M. Wasan, G. Lopez-Berestein, The past, present, and future uses of liposomes in treating infectious diseases, Immunopharmacol. Immunotoxicol. 17 (1995) 1-15.
5. T.M. Allen, Liposomes opportunities in drug delivery, Drugs 54S4 (1997) 8-14.
6. I.A.J.M. Bakker-Woudenberg, A.F. Lokerse, M.T. tenKate, P.M. Melissen, W. vanVianen, E.W. vanEtten, Liposomes as carriers of antimicrobial agents or immunomodulatory agents in the treatment of infections, Eur. J. Clin. Microbiol. Infect. Dis. 12S1 (1993) S61-67.
7. A.J. Schroit, J. Madsen, R. Nayar, Liposome-cell interactions: in vitro discrimination of uptake mechanism and in vivo targeting strategies to mononuclear phagocytes, Chem. Phys. Lipids 40 (1986) 373-393.
8. G. Storm and M.C. Woodle, Long-circulating liposome therapeutics: from concept to clinical reality, in: M.C. Woodle and G. Storm (Eds.), Long Circulating Liposomes: Old Drugs, New Therapeutics. Springer-Verlag, Berlin, 1998, pp. 3-16.
9. D. Papahadjopoulos, T.M. Allen, A. Gabizon, E. Mayhew, K. Matthay, S.K. Huang, K.-D. Lee, M.C. Woodle, D.D. Lasic, C. Redemann, F.J. Martin, Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy, Proc. Natl. Acad. Sci. USA 88 (1991) 11460-11464.
10. M.C. Woodle, M.S. Newman and P.K. Working, Biological properties of sterically stabilized liposomes, in: D.D. Lasic and F.J. Martin (Eds.), Stealth Liposomes. CRC Press, Boca Raton, FL, 1995, pp. 103-117.
11. I.A.J.M. Bakker-Woudenberg, A.F. Lokerse, M.T. tenKate, G. Storm, Enhanced localization of liposomes with prolonged blood circulation time in infected lung tissue, Biochim. Biophys. Acta 1138 (1992) 318-326.
12. I.A.J.M. Bakker-Woudenberg, A.F. Lokerse, M.T. tenKate, J.W. Mouton, M.C. Woodle, G. Storm, Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue, J. Infect. Dis. 168 (1993) 164-171.
13. I.A.J.M. Bakker-Woudenberg, M.T. tenKate, L.E.T. Stearne-Cullen, M.C. Woodle, Efficacy of gentamicin or ceftazidime entrapped in liposomes with prolonged blood circulation and enhanced localization in Klebsiella pneumoniae-infected lung tissue, J. Infect. Dis. 171 (1995) 938-947.
14. O.C. Boerman, W.J. Oyen, G. Storm, M.L. Corvo, L. vanBloois, J.W. vanderMeer, F.H. Corstens, Technetium-99m labeled liposomes to image experimental arthritis, Ann. Rheum. Dis. 56 (1997) 369-373.
15. W.J. Oyen, O.C. Boerman, E.T. Dams, G. Storm, L. vanBloois, E.B. Koenders, U.J. vanHaelst, J.W. vanderMeer, F.H. Corstens, Scintigraphic evaluation of experimental colitis in rabbits, J. Nucl. Med. 38 (1997) 1596-1600.
16. W.J. Oyen, O.C. Boerman, G. Storm, L. vanBloois, E.B. Koenders, R.A. Claessens, R.M. Perenboom, D.J.A. Crommelin, J.W. vanderMeer, F.H. Corstens, Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes, J. Nucl. Med. 37 (1996) 1392-1397.
17. V. Awasthi, B. Goins, R. Klipper, R. Loredo, D. Korvick, W.T. Phillips, Imaging experimental osteomyelitis using radiolabeled liposomes, J. Nucl. Med. 39 (1998) 1089-1094.
18. I.A.J.M. Bakker-Woudenberg, J.C. vandenBerg, M.F. Michel, Therapeutic activities of cefazolin, cefotaxime, and ceftazidime against experimentally induced Klebsiella pneumoniae pneumonia in rats, Antimicrob. Agents Chemother. 22 (1982) 1042-1050.
19. A. Gabizon, J. Huberty, R.M. Straubinger, D. Papahadjopoulos, An improved method for in vivo tracing and imaging of liposomes using a gallium 67-deferoxamine complex, J. Liposome Res. 1 (1988) 123-135.
20. G.R.J. Bartlett, Phosphorus assay in column chromatography, J. Biol. Chem. 234 (1959) 466.
21. J. Kurantsin-Mills, H.M. Jacobs, R. Siegel, M.M. Cassidy, L.S. Lessin, Indium-111 oxine labeled erythrocytes: cellular distribution and efflux kinetics of the label, Int. J. Rad. Appl. Instrum. B 16 (1989) 821-827.
22. T.M. Allen, C. Hansen, Pharmacokinetics of stealth versus conventional liposomes: effect of dose, Biochim. Biophys. Acta 1068 (1991) 133-141.
23. R.A. Demel, B. DeKruyff, The function of sterols in membranes, Biochim. Biophys. Acta 457 (1976) 109-132.
24. T.M. Allen, C. Hansen, F. Martin, C. Redemann, A. Yau-Young, Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo, Biochim. Biophys. Acta 1066 (1991) 29-36.
25. M.W. Dewhirst and D. Needham, Extravasation of Stealth liposomes into tumors: direct measurement of localization and vascular permeability using a skin flap window chamber, in: D.D. Lasic and F.J. Martin (Eds.), Stealth Liposomes. CRC Press, Boca Raton, FL, 1995, pp. 127-137.
26. O.C. Boerman, W.J. Oyen, L. vanBloois, E.B. Koenders, J.W. vanderMeer, F.H. Corstens, G. Storm, Optimization of technetium-99m-labeled PEG-liposomes to image focal infection: effects of particle size and circulation time, J. Nucl. Med. 38 (1997) 489-493.
27. D.C. Litzinger, A.M. Buiting, N. vanRooijen, L. Huang, Effect of size on the circulation time and intraorgan distribution of amphiphatic poly(ethylene glycol)-containing liposomes, Biochim. Biophys. Acta 1190 (1994) 99-107.
28. C. Beaulac, S. Clement-Major, J. Hawari, J. Lagace, Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramycin in an animal model of chronic pulmonary infection, Antimicrob. Agents Chemother. 40 (1996) 665-669.
29. I.A.J.M. Bakker-Woudenberg, A.F. Lokerse, F.H. Roerdink, Antibacterial activity of liposome-entrapped ampicillin in vitro and in vivo in relation to the lipid composition, J. Pharmacol. Exp. Ther. 251 (1989) 321-327.
30. A. Nagayasu, T. Shimooka, H. Kiwada, Effect of vesicle size on in vivo release of daunorubicin from hydrogentaed egg phosphatidylcholine-based liposomes into blood circulation, Biol. Pharm. Bull. 18 (1995) 1020-1023.
31. M. Silvander, M. Johnsson, K. Edwards, Effects of PEG-lipids on permeability of phosphatidylcholine/cholesterol liposomes in buffer and in human serum, Chem. Phys. Lipids 97 (1998) 15-26.
32. C. Beaulac, S. Clement-Major, J. Hawari, J. Lagace, In vitro kinetics of drug release and pulmonary retention of microencapsulated antibiotic in liposomal formulations in relation to the lipid composition, J. Microencapsul. 14 (1997) 335-348.
33. M.C. Woodle, K.K. Matthay, M.S. Newman, J.E. Hidayat, L.R. Collins, C. Redemann, F.J. Martin, D. Papahadjopoulos, Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes, Biochim. Biophys. Acta 1105 (1992) 193-200.
34. M.C. Woodle, L.R. Collins, E. Sponsler, N. Kossovsky, D. Papahadjopoulos, F.J. Martin, Sterically stabilized liposomes. Reduction in electrophoretic mobility but not electrostatic surface potential, Biophys. J. 61 (1992) 902-910.
35. R. Zeisig, K. Shimada, S. Hirota, D. Arndt, Effect of sterical stabilization on macrophage uptake in vitro and on thickness of the fixed aqueous layer of liposomes made from alkylphosphocholines, Biochim. Biophys. Acta 1285 (1996) 237-245.
36. A.A. Gabizon, Liposome circulation time and tumor targeting: implications for cancer chemotherapy, Adv. Drug Del. Rev. 16 (1995) 285-294.